Scientific Standards for 23andMe's Health and Trait Reports
This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.
- Publisher
- 23andMe
- Published
- Length
- 8 pages
- File
- 240 KB PDF
β¬
Download the full 8-page PDF
Free Β· 240 KB Β· Instant access after email
# Executive Summary
This white paper details the scientific standards employed by 23andMe for their Health and Trait reports, focusing on:
- **Clinical and Analytical Validity**: Reports must meet strict standards for validity and reliability.
- **Evidence Sources**: Genetic associations are based on peer-reviewed studies and clinical guidelines.
- **Report Types**: Includes Carrier Status, Genetic Health Risk, and Pharmacogenetics reports, each with specific criteria for variant inclusion.
- **Regulatory Compliance**: All reports are regulated by the U.S. FDA to ensure clinical and analytical validity.
- **Evaluation Criteria**: Studies are assessed for population size, methodology, and statistical significance to ensure robust findings.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.